- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05473871
Enhancing Capacity in Churches to Implement PA Programs
March 20, 2023 updated by: Elva Arredondo, San Diego State University
Enhancing Capacity in Faith-based Organizations to Implement and Sustain Multilevel Innovations to Improve Physical Activity
Despite the benefits of physical activity (PA) to prevent cardiovascular disease and other chronic diseases, few adult Latinas meet PA guidelines.
Given the central role of churches within the Latino community and their commitment to the well-being of their members, they are ideal settings for health promotion.
Evidence-based interventions (EBIs) for increasing PA and reducing obesity exist, but few PA interventions go to scale.
Investigators propose to enhance Faith in Action with three organization-level strategies designed to increase program fit and effectiveness: 1) training church leaders in health promotion; 2) tailoring messaging to enhance fit between Faith in Action and each unique church environment; and 3) empowering community health workers (promotoras) to advocate for organizational change.
Given the need to improve strategies to sustain health programs in community settings, investigators will test the influence of two additional sustainment strategies: 1) strengthening community collaborations and 2) providing technical support.
Thirty-two churches will be randomly assigned to a Standard EBI group (Faith in Action as originally implemented), an Enhanced group (Standard intervention + organizational-level implementation strategies), or an Enhanced + Sustainment group (Enhanced implementation group + sustainment strategies).
Investigators will test the proposed implementation strategies on organization-level change and individual behavior in diverse churches for a 12-month intervention and 6-month follow-up period.
The proposed study aims to: 1) Test the short and long-term impacts of organization-level implementation strategies in 2 Enhanced conditions on organizational outcomes compared to the Standard EBI condition and 2) Examine individual behavior change among Latinas (N=812) in churches in the 2 Enhanced conditions compared to the Standard EBI condition.
The study's primary hypothesis is that Latina's receiving the Enhanced interventions will increase their PA levels significantly more than those receiving the Standard Faith in Action intervention, and the improvements in PA will be sustained.
If successful, findings from the current study will provide evidence of organizational-level strategies for uptake, sustainment, and implementation strategies for scale-up of PA interventions to increase PA and reduce chronic disease in churches across the US.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study, guided by PRISM/RE-AIM frameworks, will use a pragmatic, cluster randomized controlled design to stratify by faith-based organization (FBO) size, and randomly assign 32 FBOs to one of 3 conditions: a Standard implementation condition (n=8 FBOs), an Enhanced implementation condition (Standard + organizational implementation strategies; n=12 FBOs), or an Enhanced + Sustainment condition (Enhanced + sustainment strategies; n=12 FBOs) for a 12-mo intervention with a 6-month sustainment follow- up period.
This design offers the opportunity to examine the impact of explicit implementation and sustainment strategies compared to the Standard EBI condition to advance the science on scaling up EBIs.
Investigators will allocate more churches in the Enhanced conditions to provide more opportunities to test the implementation process and impact of the proposed strategies in diverse church contexts.
This design will allow investigators to examine the additive impact of the organization-level implementation strategies on both organizational outcomes (Aim 1) and individual outcomes (Aim 2).
Investigators will examine the potential mechanisms of action (Secondary Aim 1) of the organizational implementation strategies.
At 12 months post-baseline, FBOs in the Standard (n=8) and Enhanced condition (n=12) will receive no additional support while FBOs in the Enhanced + Sustainment condition (n=12) will receive additional program support (Secondary Aim 2) to examine the impact of sustainment strategies on both program and participant PA sustainment over an additional 6 months.
Quantitative and qualitative data will be collected at baseline, 6 months, 12 months, and 18 months post baseline.
Study Type
Interventional
Enrollment (Anticipated)
812
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Katia Garcia, BA
- Phone Number: 619-594-6307
- Email: kgarcia6@sdsu.edu
Study Contact Backup
- Name: Tasi Rodriguez, MPH
- Phone Number: 619-594-3059
- Email: trodriguez@sdsu.edu
Study Locations
-
-
California
-
San Diego, California, United States, 92182
- Recruiting
- San Diego State University Research Foundation
-
Contact:
- Tasi Rodriguez
- Phone Number: 619-594-3059
- Email: trodriguez@sdsu.edu
-
Contact:
- Katia Garcia
- Phone Number: 619-594-6307
- Email: kgarcia6@sdsu.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Self-identifying as Latina
- Aged 18-65 years
- Planning on attending the FBO for the next 18 months
- Low self-reported leisure-time MVPA (<50 min of weekly leisure MVPA)
- No health factors interfering with PA
Exclusion Criteria:
- Anyone with a health condition precluding them from engaging in PA
- Cognitive impairment preventing participation
- Inability to complete the informed consent in English or Spanish
- Attending other churches besides the church of recruitment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Standard EBI Condition
Faith in Action as originally implemented
|
Interpersonal level: Group exercise classes offered 6 days/week (walking, cardio dance, strength training), Kickoff event Individual level: Motivational Interviewing calls every 6 months, Health handouts on 14 topics distributed at PA classes |
Experimental: Enhanced Condition
Standard condition + organizational-level implementation strategies
|
Standard Faith in Action Intervention plus: 1) Health Behavior Change Workshop for FBO leaders; 2) Targeted Messaging; and 3) Empowerment Training for Promotoras
|
Experimental: Enhanced + Sustainment condition
Enhanced implementation condition + maintenance strategies
|
Enhanced Condition plus: 1) Foster community collaborations and 2) Provide maintenance support
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Organizational Level: Change in Innovation-Values fit from Baseline to Month 6
Time Frame: 6 months
|
Investigators will survey FBO leaders, church staff, promotoras, and parishioners to assess the change in Innovation-values fit from baseline to month 6.
Self-report questions regarding perceptions of the fit between the values of their FBO and the Faith in Action intervention will be measured using Likert scales (completely agree to completely disagree).
|
6 months
|
Organizational Level: Change in Innovation-Values fit from Baseline to Month 12
Time Frame: 12 months
|
Investigators will survey FBO leaders, church staff, promotoras, and parishioners to assess the change in Innovation-values fit from baseline to month 12. Self-report questions regarding perceptions of the fit between the values of their FBO and the Faith in Action intervention will be measured using Likert scales (completely agree to completely disagree).
|
12 months
|
Individual Level: Change in Participants' Moderate to Vigorous Physical Activity (MVPA) from Baseline to Month 6
Time Frame: 6 months
|
Investigators will assess the change in the number of minutes per day of participants' MVPA from baseline to month 6.
|
6 months
|
Individual Level: Change in Participants' Moderate to Vigorous Physical Activity (MVPA) from Baseline to Month 12
Time Frame: 12 months
|
Investigators will assess the change in the number of minutes per day of participants' MVPA from baseline to month 12.
|
12 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Organizational Level: Maintenance of Promotoras' PA Class Delivery
Time Frame: 18 months post-baseline
|
Investigators will assess if the promotoras are delivering at least 3 PA classes per week at their church.
|
18 months post-baseline
|
Organizational Level: Maintenance of Promotoras' MI Calls
Time Frame: 18 months post-baseline
|
Investigators will assess if promotoras have made at least 1 MI call.
|
18 months post-baseline
|
Individual Level: Maintenance of Moderate to Vigorous Physical Activity (MVPA) at 18 months
Time Frame: 18 months post-baseline
|
Investigators will compare the number of minutes of participants' MVPA per day at 18 months to baseline, 6, and 12 months, to assess maintenance of MVPA at 18 months, which will be 6 months after the intervention has ended.
|
18 months post-baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Elva Arredondo, PhD, San Diegp State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 15, 2022
Primary Completion (Anticipated)
May 1, 2026
Study Completion (Anticipated)
October 31, 2026
Study Registration Dates
First Submitted
July 21, 2022
First Submitted That Met QC Criteria
July 25, 2022
First Posted (Actual)
July 26, 2022
Study Record Updates
Last Update Posted (Actual)
March 22, 2023
Last Update Submitted That Met QC Criteria
March 20, 2023
Last Verified
March 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- R01HL158538 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
The final dataset will be an electronic database containing objective (BMI and Blood Pressure) and self-report (survey with primary and secondary outcomes, demographic information, etc.) variables from baseline, 6, 12, and 18 months.
Data will be de-identified to remove all subject identifiers.
IPD Sharing Time Frame
Data will become available after initial data analyses and preparation of major publications.
IPD Sharing Access Criteria
Researchers interested in accessing the data must complete a registration process and must agree to the conditions of use, including restrictions against attempting to identify study participants, destruction of the data after analyses are completed, reporting responsibilities, restrictions on redistribution of the data to third parties, and proper acknowledgement of the data resource.
Those interested in accessing data must submit a brief proposal describing the intended use of the data; the investigative team will determine the scientific soundness of the proposal, as well as whether adequate data protections in place, as part of the decision for the researcher to be able to access the dataset.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
- ICF
- ANALYTIC_CODE
- CSR
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiovascular Diseases
-
Medical College of WisconsinRecruitingCardiovascular Diseases | Cardiovascular Risk Factor | Cardiovascular HealthUnited States
-
Hospital Mutua de TerrassaCompleted
-
Oregon Health and Science UniversityCompletedCardiovascular Disease | Cardiovascular Risk FactorsUnited States
-
Women's College HospitalUniversity Health Network, Toronto; Sunnybrook Health Sciences Centre; Brigham... and other collaboratorsUnknownCARDIOVASCULAR DISEASESCanada, United States
-
Groupe Hospitalier Paris Saint JosephTerminatedCARDIOVASCULAR DISEASESFrance
-
University of FloridaUniversity of Alabama at Birmingham; Brown UniversityCompletedCardiovascular Disease | Psychosocial Influence on Cardiovascular DiseaseUnited States
-
VA Office of Research and DevelopmentNot yet recruitingCardiovascular DiseaseUnited States
-
Baptist Health South FloridaUniversity of California, Los Angeles; Quest Diagnostics-Nichols InsituteActive, not recruitingCardiovascular DiseaseUnited States
-
Laval UniversityActive, not recruitingCardiovascular DiseaseCanada
-
Penn State UniversityCalifornia Healthcare InstituteCompleted
Clinical Trials on Faith in Action
-
Cedars-Sinai Medical CenterCalifornia Breast Cancer Research ProgramRecruitingFaith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean WomenHealth Knowledge, Attitudes, Practice | Breast Cancer Female | Health Disparities | Cancer ScreeningUnited States
-
Temple UniversityNational Institute on Disability, Independent Living, and Rehabilitation...Recruiting
-
Mayo ClinicJohns Hopkins University; National Institute on Minority Health and Health... and other collaboratorsNot yet recruitingCardiovascular Diseases | Health Equity
-
San Diego State UniversityNational Cancer Institute (NCI)Completed
-
Emory UniversityNational Institute on Aging (NIA)Completed
-
University of Texas Southwestern Medical CenterCompletedHypertension | Obesity | Cardiovascular Disease | DiabetesUnited States
-
Melicia Whitt-GloverNational Heart, Lung, and Blood Institute (NHLBI); University of North Carolina... and other collaboratorsCompleted
-
University of MinnesotaCompletedTobacco Use | Text Messaging | Faith-Based | Community-engagedUnited States
-
Yeşim KAYAPARecruiting
-
Mayo ClinicMiami Heart Research Institute Inc.Not yet recruitingHypertensionUnited States